Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Imago Biosciences Inc (NQ: IMGO ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Imago Biosciences Inc < Previous 1 2 3 Next > 7 Healthcare Stocks That Will Be Big Winners in 2023 January 31, 2023 Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider. Via InvestorPlace 5 Top Pharma Stocks of 2022 to Buy for the Long Haul January 06, 2023 The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. Via InvestorPlace Looking Into Imago BioSciences's Recent Short Interest January 04, 2023 Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular... Via Benzinga 5 Most Expensive Health Care Stocks You Should Worry About January 03, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Merck Begins Tender Offer to Acquire Imago BioSciences, Inc. December 12, 2022 From Merck & Co., Inc. Via Business Wire Analyst Ratings for Imago BioSciences November 28, 2022 Via Benzinga What 5 Analyst Ratings Have To Say About Imago BioSciences November 22, 2022 Via Benzinga Expert Ratings for Imago BioSciences November 22, 2022 Via Benzinga How Is The Market Feeling About Imago BioSciences? December 09, 2022 Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 13.61% of all regular... Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT) December 05, 2022 From Brodsky & Smith LLC Via GlobeNewswire 3 Dow Stocks to Take Seriously in 2023 November 29, 2022 The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022 November 28, 2022 Via Benzinga IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Imago BioSciences, Inc. - IMGO November 22, 2022 From Kahn Swick & Foti, LLC Via Business Wire Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday November 22, 2022 Via Benzinga TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune November 22, 2022 Via AB Newswire Topics Death Economy Stocks Exposures COVID-19 Death Interest Rates Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday November 22, 2022 Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash. Via Benzinga Nasdaq Down More Than 100 Points; Gold Falls 1% November 21, 2022 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday. Via Benzinga Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session November 21, 2022 Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 21, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Monday November 21, 2022 During Monday's session, 50 stocks hit new 52-week highs. Via Benzinga OPEC Rumors, Energy Stocks Drag Wall Street November 21, 2022 The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well. Via Talk Markets Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher November 21, 2022 U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday. Via Benzinga Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday November 21, 2022 U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion November 21, 2022 Imago BioSciences, Inc. (NASDAQ: IMGO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development Via Spotlight Growth As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled November 21, 2022 Markets sent mixed messages to start out Thanksgiving week. Via The Motley Fool Why Is Imago Biosciences (IMGO) Stock Up 105% Today? November 21, 2022 Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. Via InvestorPlace Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney November 21, 2022 U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday. Via Benzinga Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout November 21, 2022 Seagen who? Merck is putting its cash to work buying a smaller biotech company. Via Investor's Business Daily IMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to Shareholders November 21, 2022 From Halper Sadeh LLC Via Business Wire Cancer-Focused Imago BioSciences Shares Soar After Merck Deal November 21, 2022 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.